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Since the first publication about them in 1935,1
inflammatory abdominal aneurysms (IAAAs) have
been frequently reported in the literature, with an
incidence ranging from 4% to 5.1% in recent years.2-4
Although it is still not certain whether they are an
independent entity or only represent the extreme
end in the spectrum of an immanent inflammatory
aspect in all abdominal aneurysms,3,5 IAAAs are
considered a distinct clinical syndrome with well-
defined pathologic findings and specific therapeutic
problems.4,6-10 The first reports were very optimistic
about the course of the disease after surgical repair
or even biopsy alone.4,7,8,11,12 In large series, com-
plete remission of symptoms was observed, and it
was assumed that entire regression of the patholog-
ic changes would ensue. Lately, this view has been
challenged.2,13,14 Progression of fibrosis after
surgery or postoperative development of organ com-
plications in previously uninvolved structures are
rarely described and not considered to be of major
importance to the further course of the disease,
although development of secondary renal atrophy is
well known.3,7,10,14-17 If these patients could be
identified, however, it would be possible to avoid
subsequent organ damage.
PATIENTS AND METHODS
From 1988 to 1997, 1035 patients underwent
surgery for an abdominal aneurysm; 42 (4.1%) of
these patients had typical signs of inflammation.7,10
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The diagnosis was made by means of computed
tomography (CT) scan findings, the appearance at
surgery, and pathology specimens, when available
(n = 15).
To clarify the fate of patients with inflammatory
aneurysms, all patients still living were asked to
undergo a follow-up CT scan, either at our institu-
tion or a suitable facility of their choice. Only patients
with both preoperative and postoperative CT scans
were included in the study. Imaging for 26 patients
could be retrieved. The images were reviewed by a
radiologist who was unaware of the case and the clin-
ical outcome. A careful case history was taken from
the patient and from the doctor in attendance.
Predisposing factors and the postoperative course,
especially family history of aneurysms, anti-inflamma-
tory medication, smoking history, renal problems,
and the typical signs of inflammatory aneurysms,
were assessed. The operative reports were reviewed
for the extension of the inflammatory process, organs
involved, ureterolysis, and suprarenal clamping or
renal artery revascularization. In the remaining 16
cases, which could not be followed up, the records
were reviewed and the case history was taken, from
patients when possible or from the last attending
doctor and relatives. The primary CT reports were
reevaluated for overlooked or misinterpreted lesions.
In the statistical analysis, we compared data by
means of either regression analysis or c 2 test,
depending on suitability. Significance was defined as
a P value of less than .05.
RADIOLOGICAL EXAMINATION
Eleven of the 26 preoperative scans were per-
formed at our institution. In the follow-up period,
four patients could be reviewed by our radiology
department. The remaining chose institutions closer
to their home. All patients had at least one preoper-
ative and one postoperative scan done. In five cases,
three or more scans could be retrieved.
Precise assessment of the inflammatory layer
poses considerable problems. To our knowledge, the
only study with a precise description of the assess-
ment procedure was published by Baskervill et al in
1983.18 Persistent fibrosis does not manifest itself
homogeneously around the aorta, but is undulating
in appearance. Therefore, the thickest part might
only represent a small portion of the circumference,
whereas the remaining area might show only rela-
tively mild changes. A changing capacity of the layer
to take up contrast medium (probably correspond-
ing to the histological type: high cell density versus
fibrotic) but also varying scan parameters of differ-
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ent institutions (speed of injection, scan intervals,
zoom, spiral mode), make comparisons difficult. Ill-
defined borders of the inflammatory layer in the case
of dense adhesions tended to influence the result.
Measurement of the volume over a well-defined axis,
as suggested by Baskervill, could improve the com-
parability of results, but offers no solution to the
other problems mentioned.
We therefore chose not to pick the thickest part
of fibrosis, but rather looked for corresponding areas
with well-defined borders in the preoperative and
postoperative CT scans. Only when the mean varied
by 25% was the course judged as different to the pre-
operative findings. The results were graded as
unchanged, partial remission, complete remission,
or progression. 
Fibrosis was judged to be the layer with soft-tissue
density immediately covering the mostly calcified inti-
ma with marked enhancement after injection of con-
trast medium. The overall determination of the wall
thickness was always easy to determine, because the
lumen was sharply delineated by the contrast medi-
um, as was the outer margin by surrounding soft tis-
sue. Dense adhesions, however, might lead to poorly
defined margins in the anterior aspect. Therefore,
exact demonstration of the layered mural structure,
especially of persisting fibrosis, is only possible with
native and consecutive contrast-enhanced scans,
although enhancement of the fibrotic process might
be variable. Fibrosis presents itself with low signal
intensity in the native scans, resembling signal inten-
sity of vessels after injection of contrast medium. If
the intravenous injection is performed without previ-
ous scans, it will be impossible to discriminate among
fibrosis, diffuse calcification, leakage, or dissection. 
Only nine of 22 examinations carried out in
other institutions were performed with native as well
as contrast-enhanced techniques. The lack of stan-
dardized contrast medium application therefore
posed the biggest problem in the interpretation of
the follow-up scans. In selected cases, it was only by
the individual course and orientation at landmarks,
such as renal arteries or prominent calcifications,
that the fibrotic layer could be judged. 
RESULTS
The mean age of patients was 70.5 years; 95% of
patients (40 of 42) were men. The size of aneurysm
ranged from 5.5 to 12 cm (mean, 6.4 cm), and the
mean follow-up time was 38 months (range, 0 to 92
months). Surgery was elective in 27 cases (67.5%),
urgent (within 48 hours) in four cases (5%), and
emergency in 11 cases (27.5%). 
Two patients died perioperatively, and six patients
died during the follow-up period, of reasons unrelat-
ed to the underlying disease. Three patients refused
to attend, four patients were too old and weak to par-
ticipate, and one patient was lost to follow-up. 
In the seven cases for which follow-up was not pos-
sible, the attending doctor and the patient were inter-
viewed. Although no urinary complications or other
problems were reported, we judged the information as
not sufficiently reliable, and only present complaints
related to the inflammatory process were used.
Preoperative findings. Seventy-four percent of
patients were symptomatic on presentation. Clinical
symptoms varied, but abdominal pain (19 of 42
patients), chronic lumbar pain (8 of 42 patients) or
tenderness on palpation (13 of 42 patients), and sig-
nificant weight loss (4 of 42 patients) were the most
common complaints. Four patients were treated for
nonspecific back pain, in some cases for years, until
the correct diagnosis was made. Fever was uncom-
mon and only reported by three patients.
Eight patients were referred with suspected rup-
ture, but only two patients turned out to have a rup-
ture, one patient with aortocaval fistula. The other
patients were operated on in a hemodynamically sta-
ble condition and, in four cases, showed chronic con-
tained rupture. Dissection was not noted, although it
was suspected in three cases preoperatively. In these
cases and in the remaining cases of suspected rupture,
the typical contrast enhancement of the inflammato-
ry layer was misinterpreted to be a lesion to the wall
integrity by the referring radiologist. 
Ureteral involvement was found in nine patients
(21.4%) and led to hydronephrosis in eight cases,
bilateral in one patient. Signs of renal atrophy were
diagnosed in four patients on admission, three of
whom had ureteral obstruction.
Three patients complained of intermittent symp-
toms related to small bowel obstruction and delayed
gastric emptying.
In contrast with other authors who found a pos-
itive family history in 17% of patients,14,19 none of
our patients could recollect a similar disease in their
close relatives (parents and siblings). Also, a higher
prevalence of current smokers could not be con-
firmed in our group. They were found to be equally
represented in inflammatory and noninflammatory
abdominal aortic aneurysms (48.2% and 45.7%,
respectively), although overall prevalence of ciga-
rette use was similarly high (ever smoked: 81.5% and
80.6%, respectively).
Surgical management and operative findings.
A transperitoneal approach was used in all cases.
Straight grafts were implanted in 20 patients; bifur-
cated grafts were implanted in the remaining 22
patients. All aneurysms showed the typical whitish
surface and dense perianeurysmal fibrosis that usual-
ly spread from the level of the renal arteries to the
bifurcation. In one patient, a significant suprarenal
extension was noted, whereas the common iliac
artery was included in five patients. Infrarenal
clamping proved possible in all but five patients. In
the case in which inflammation extended to the tho-
racoabdominal aorta (Crawford IV), the aneurysm
was bypassed during reconstruction.
The third part of the duodenum was adherent to
the aneurysm in all cases. The sigmoid colon was
adherent in two cases, and the small intestine was
adherent in five cases. Iatrogenic injury to the intes-
tine occurred in three cases. Ureteral involvement was
not ascertained routinely, except when hydronephro-
sis or renal atrophy was present. In the first years, we
strove to liberate the ureter in these cases, but because
complete obstruction seldom occurs and spontaneous
remission of hydronephrosis after surgical repair
turned out to be the most likely course, we modified
our concept to preoperative implantation of a ureter-
al catheter. Ureterolysis is performed only when this
procedure fails, which happened in four cases. The left
renal vein was adherent in 25 patients and was ligated
for better access in 14 cases. The renal artery was
involved in the inflammatory process in four cases to
such an extent that safe infrarenal clamping was not
possible. Aortorenal reconstruction was carried out in
all these patients.
The inferior mesenteric artery could only be
reinserted in two aneurysms because of occlusion of
the vessel or thickness of the aortic wall. 
Outcome. In five patients, early reoperation
was necessary, twice because of bleeding after subdi-
aphragmal clamping and one time each after lacera-
tion of the spleen, ischemic colon with peritonitis,
and severe pancreatitis. Four of these patients were
operated on as an emergency, two who had a con-
tained rupture and one with acute rupture and sub-
sequent hypovolemic shock on admission. The
patient with bowel ischemia died after peritoneal
lavage. Bleeding from subdiaphragmal vessels led to
the death of the second patient. No late graft-relat-
ed complications occurred.
Seven patients had intermittent renal failure, but
dialysis was required in one patient only for two
weeks. Two of these patients were operated on in
hypotension; four other patients had concomitant car-
diac disease and prolonged cross-clamp time. In four
patients, developing hydronephrosis was observed. A
JOURNAL OF VASCULAR SURGERY
1092 von Fritschen et al December 1999
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 6 von Fritschen et al 1093
compartment syndrome developed in one patient
after peripheral embolism, and bypass graft recon-
struction was needed. Ischemic nontransmural enter-
opathy was diagnosed in three patients (7.14%), but it
resolved spontaneously after prolonged parenteral
nutrition in all cases. 
In the time from operation to follow-up exami-
nation, six more patients died. Four patients had car-
diac infarction (1 to 4 years later), another patient
had cancer of the colon, and the last patient died of
unknown reasons that were not related to the
aneurysm, according to the last attending physician. 
Hydronephrosis disappeared in all cases in which
ureterolysis was performed and did not recur. In the
remaining cases of hydronephrosis (Table I) and the
clinically silent adhesions, spontaneous resolution of
the ureteral obstruction was noticed after aneurysm
repair, with the exception of two patients in whom
pre-existing parenchymal defects or hydronephrosis
worsened to renal atrophy (patients 5 and 6).
Another patient improved to persistent moderate
hydronephrosis (patient 19). Three patients devel-
oped renal atrophy of probable vascular origin
(patients 1, 4, and 15), and in one patient, the etiol-
ogy remains obscure (patient 17).
In three cases (patients 9, 11, and 12), we unex-
pectedly noted development of hydronephrosis early
after surgery in previously asymptomatic patients, all
of whom had a significant rise in creatinine levels
(1.6 to 1.9 mg/dL). Intravenous pyelogram could
exclude isolated ureteral strictures because of sutures
or at the point of crossing the iliac artery, because
one patient had a bifurcated graft implanted. In one
case, there was continuous progression and a dou-
ble-J stent was inserted (patient 12). The other two
cases were closely followed up; spontaneous remis-
sion was observed in one patient, and a marked
improvement was observed in the other patient.
Creatinine levels returned to normal, and only a pro-
longed drainage on intravenous urogram could be
demonstrated in the second patient (patient 11).
Three patients had late ureteral obstruction. One
patient was readmitted 14 months postoperatively
with abdominal pain, an elevation of the erythrocyte
sedimentation rate (ESR) to 65 mm/h, and severe
hydronephrosis (patient 8). Retroperitoneal fibrosis
that almost doubled its volume and led to massive
ureteral encasement with obstruction and medial
deviation was revealed with a CT scan (Figs 1 and 2).
A catheter could be installed, but several attempts to
remove it later resulted in persistent ureteral obstruc-
tion, and a new catheter needed to be placed every
time. The patient is receiving corticosteroid therapy.
In the second case, mild hydronephrosis and an
adherent ureter with no marked increase of the ESR
or creatinine level was detected with follow-up exam-
ination 3 years after surgery (patient 10). The third
patient (patient 12) was discharged after installation
Table I. Clinical outcome in patients with extravascular inflammatory organ involvement
Hydronephrosis Ureter Renal compromise Intestine
Patient Diameter Time
number Preop Postop Now Preop Now Preop Now Preop Now Fibrosis (cm) (months)
1 – – – L – – R – – p 5.5 15
2 L – – L – – – – – p 7.3 60
3 LR – – L>R – – – – – cr 6 60
4 L – – L – L LR – – cr 10 66
5 L L L L L L L – – = 4.2 35
6 L L – L L – L – – = 4 91
7 L – – L – – – – – cr 5 17
8 – – R – R – – – – + 5 18
9 – L – – – – – – – p 12 40
10 – – R – R – R – – p 6 31
11 – L (L) – L – – + (+) = 7.5 23
12 – L R – R – L – + p 9 23
13 – – – – + 7.5 –
14 – – – – – – – + – p 10 38
15 – – – – – – L – – = 8 28
16 – – – – – R R – – = 6.4 32
17 – – – – – – L – – cr 5 22
18 L – L – 6.5 –
19 L L L L 5.5 –
Preop, Preoperatively; Postop, postoperatively; Now, at time of follow-up; R, right; L, left; Ureter, ureter entrapped in inflammatory layer;
(), improvement compared with the preoperative findings; p, persistent; cr, complete remission; =, no change; +, progression.
Fig 1. Preoperative computed tomography scan with typ-
ical image of inflammatory aneurysm: layer of fibrotic tis-
sue surrounding the calcified aneurysmal wall.
Fig 2. Computed tomography scan of patient in Fig 1 at
16 months postoperatively showing the patent graft sur-
rounded by calcified aneurysmal wall and marked increase
in the thickening of the inflammatory layer. Note installed
ureteral catheter on the right side.
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of a ureteral catheter and an otherwise uneventful
course. He was readmitted to a gastroenterologic unit
after 6 months with the signs and symptoms of chron-
ic intestinal obstruction. The ureteral catheter was
removed on the left side, leaving the kidney with mild
signs of atrophy. With coloscopy, a 9-cm tense ob-
structing segment of the sigmoid colon was found. No
ulcerations or other signs of ischemia could be detect-
ed; nonspecific inflammation was confirmed with a
pathological examination. The stenosis was judged to
be ischemic after ligation of the inferior mesenteric
artery and was endoscopically dilated consecutively.
This lead to perforation, which was overlooked at first,
and an emergency operation at another institution.
The adherent sigmoid was liberated from the aneu-
rysm, and the lesion was sutured. A connection to the
underlying inflammatory process was not realized,
however, and it led to the failure of starting a steroid
therapy. The patient made an uneventful recovery, but
severe hydronephrosis on the contralateral side devel-
oped. Although it is debatable whether ischemia might
have caused the bowel obstruction, an inflammatory
component is not unlikely. 
Three other patients had symptomatic bowel
involvement and signs of duodenal obstruction post-
operatively. Two of these patients also belonged 
to the group of patients in whom postoperative
hydronephrosis developed. The third part of the
duodenum and proximal jejunum were dissected in
these cases, but symptoms did not subside in two
patients. During a duodenoscopy, an obstruction in
the distal duodenum was found and could success-
fully be dilated in one patient (patient 14). The
other patient refused further therapy, and although
the condition improved markedly, she still had inter-
mittent delayed gastric emptying 4 years after oper-
ation (patient 11). 
Almost all patients with the typical preoperative
symptoms of IAAA were asymptomatic on follow-
up. Occasional abdominal pain was reported by only
two of the 33 patients who could be interviewed
(6.1%); one of these patients (patient 12) had symp-
tomatic, persistent fibrosis. Chronic lumbar pain had
resolved in all but one patient, who has concomitant
degenerative disease of the lumbar spine. Four
patients complained of reduced fitness since the
operation. All of these patients had severe concomi-
tant disease (ASA 4), and three patients had a pro-
longed postoperative course that required reopera-
tion and intensive care.
Course of retroperitoneal fibrosis. Complete
remission of the inflammatory process could be
observed in only six patients (23.11%). An improve-
ment could be found in 34.6% of patients (9
patients), and a stable condition without regression
was found in 10 cases (38.5%). One patient, howev-
er, had marked progression: The fibrotic mantle
almost doubled its diameter within 18 months.
No statistically significant differences between the
groups were observed in age, sex, follow-up period,
diameter of the aneurysm, thickness of the layer, or
other risk factors. The degree of fibrosis did not cor-
relate with the risk of developing organ complica-
tions. Of the seven patients with hydronephrosis,
four patients showed only mild to moderate fibrotic
layers (5 mm or less), which was the case for two of
the patients with duodenal involvement as well.
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DISCUSSION
The incidence of inflammatory abdominal
aneurysm varies between 2.2% and 18.1% of all sur-
gically treated aortic aneurysms.3,4,20 It was suggest-
ed that this disparity might best be explained by a
spectrum in the severity of fibrosis and degree of the
underlying inflammatory process.3,9,21-24 Various
studies pointed out that there not only seems to be a
variable degree of inflammation in IAAAs, but also
some amount of inflammation in all aneurysms; at
times, even identical histopathological changes occur
without aneurysm formation.18,21,23 Nevertheless,
IAAA is a distinct clinical syndrome. Abdominal
aneurysm associated with the triad of lumbar or
abdominal pain, elevated ESR, and medial deviation
of the ureter is virtually diagnostic. 
Despite much effort, the etiology of IAAA is still
obscure, and various theories have been put forward:
Microorganisms have been considered unlikely, but
hemorrhage in the wall or subclinical leakage have
been suggested, as well as an auto-allergic reaction to
ceroid, a component of atherosclerotic plaques, or
even the possibility that AAA might develop only sec-
ondarily to inflammation.7,25-28 Also an opposite
theory has been proposed: an obstruction of lym-
phatic vessels caused by an expanding aneurysm,
leading to stasis and secondary fibrosis.24,29-31 Lately,
evidence for a genetic predisposition to the develop-
ment of the disease has been discussed.19
Present observations favor the view that the
inflammatory layer resolves completely after graft-
ing. Because CT scanning is mandatory for adequate
evaluation of the inflammatory layer and subclinical
ureteral involvement, it is likely that the degree of
persistent fibrosis was underestimated after mere
clinical and ultrasound scanning follow-up. To date,
only investigations containing a few patients with
CT scan follow-ups have been published (Table II).
They gave ground to the assumption that, despite
clinical improvement, fibrosis persists for years or
only resolves very slowly. 
In 73% of our patients, we found persisting
fibrosis; slightly more than half of these cases had no
significant change, as compared with the preopera-
tive findings, and one case had a marked progres-
sion. In contrast to other groups, there was no sta-
tistically significant correlation between the degree
of regression and the time between operation and
follow-up, the diameter of the aneurysm, or thick-
ness of the fibrotic mantle. Our results allow the
assumption that resolution in cases of smaller diam-
eter is more likely.
Observations of other authors who found a pos-
itive family history and a higher prevalence of cur-
rent smokers in patients with IAAAs could not be
confirmed.14,19
A possible limitation of the study was that fol-
low-up was not possible by all patients and that the
radiological examination was not carried out by a
single department. Image quality was generally satis-
factory, however. 
Walker et al25 reported in 1972 that operative
repair was associated with a 31% mortality rate. In
accordance with other recent reports,6,14 we found a
higher morbidity rate compared with noninflamma-
tory AAA, especially renal complications, including
intermittent renal failure. The overall in-hospital
mortality rate was not impaired. Transmural ischemic
colitis, responsible for the death of one patient, is a
well-known complication, especially after a period of
preoperative shock, with a known incidence ranging
from 4% to 27%. Nontransmural ischemia occurred
with a higher incidence (7.1%) than quoted in the lit-
erature for arteriosclerotic aneurysm.35-37
The observation that the vast majority of patients
are relieved of their symptoms after surgical interven-
tion is not new. The typical complaints of pain, fever,
and weight-loss disappear in almost all cases; ureteral
entrapment vanishes or takes a subclinical course
when an involvement persists, ie, without develop-
ment of hydronephrosis.
Our long-term surveillance uncovered two unex-
pected findings of clinical relevance. To date, persis-
tent ureteral obstruction is rarely described and sel-
dom further treated.10,15,16,28 Postoperative wors-
ening or relapse of fibrosis is reported only
sporadically.15,16
We could demonstrate that patients with IAAA
run a risk of having inflammatory organ involvement
that did not exist at the time of operation, partially
with marked delay and on occasion after months,
and that this might happen despite a resolving
fibrotic layer. 
Although we found spontaneous resolving of the
encasement of a previously adherent ureter in five of
seven cases, organ involvement that did not exist at
the time of operation developed in six patients
(14.3%). On follow-up, renal complications turned
out to be most prevalent (26.9%). Seven of our
patients had renal parenchymal defects or progressed
to renal atrophy. Three more patients had obstruct-
ed ureters that led to persisting hydronephrosis
without development of renal damage. Surprisingly,
the fibrotic layer resolved completely or showed
marked improvement in half of these patients.
In contrast to other reports that focused on the
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evolution of the fibrotic layer during follow-up, our
report holds that the assessment of the thickness of
the layer is not helpful in the prediction of complica-
tions. Additionally, we found the fibrosis generally did
not homogeneously disperse around the aorta. Thus,
measurement will comprise considerable inaccuracy.
This is reflected by our finding only a single study
with a precise description of how the assessment was
carried out. It is possible to evaluate the individual
dynamics of the process, however. Therefore, follow-
up with CT scanning should be performed to rule out
persisting fibrosis with ureteral or other organ
involvement, which requires further therapy. In all
other cases or when only renal compromise is sus-
pected, ultrasound scanning follow-up will suffice. 
The technical problems in the treatment of IAAAs
are satisfactorily solved. Mortality and morbidity rates
are identical or very close to those encountered in the
repair of arteriosclerotic aneurysms. For further
improvement of the long-term outcome, it seems
advisable to focus on adjacent organ involvement.
Experience has shown that further treatment should
not be given out of hand. We therefore advocate a
moderated follow-up scheme (Table III) to prevent
new symptoms from being interpreted as unrelated to
the aneurysm repair that had been carried out long
ago and the patient being referred according to the
organ involved to other disciplines that have limited
experience in this complex disease.
Earlier diagnosis and adequate treatment of
developing complications will contribute to further
align the long-term outcome of IAAAs and arte-
riosclerotic aneurysms.
CONCLUSION
This study documented secondary organ damage
after successful repair of IAAAs in a considerable
number of our patients. We advocate the need for a
long-term follow-up period to ensure that complica-
tions related to the inflammatory process that occur
much later are treated in an institution familiar with
this complex disease. Because dissipation of the
fibrotic layer does not necessarily go along with
decreasing ureteral involvement, follow-up with CT
scanning seems unnecessary in cases in which only
renal involvement is expected.
Table III. Follow-up scheme for inflammatory aortic aneurysm
Months 3 6 9 12 18 24 30 36 48
Ultrasound + + + + + + +
Computed tomography + + (+)
After 1 year, follow-up computed tomography scanning is performed only when extraurinary complications are expected.
Table II. Outcome of inflammatory aortic aneurysms followed up by computed tomography scans: Review 
of the literature
Baskervill15 Plate33 Nachbur32 Stotter16 Lindblad4 Stella2
1987 1988 1989 1990 1991 1993
Number 3 5 7 1 16 19
Progression 2/3 0 0 1 0 0
No change 0 0 32%
Partial regression 1/3 100% 43% 23/35 21%
Complete regression 0 0 57% 47%
CT/Ultrasound diagnostic* CT CT CT CT CT/US CT
Persistent ureter entrapment 1/3 0 3
Postoperative hydronephrosis 2 2/5 29% 1 0
Renal compromise 40% 0 0 0
Dialysis 0 0 0 0 0
Follow-up
Range (m) 4-36 1-6 4-60 1 1-96
Mean (m) 21
*In studies in which ultrasound scanning and computed tomography were used for follow-up, data acquired by mere computed 
tomography examination were used. If discrimination was not possible, the total number of patients was quoted instead.
CT, Computed tomography; US, ultrasound.
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